| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Sep'18 | Jun'18 |
|---|---|---|---|---|---|---|
Operating expenses: | ||||||
Research and development | ||||||
26,846 | 23,764 | 18,901 | 14,271 | 0 | 0 | 0 |
General and administrative | ||||||
14,245 | 11,914 | 9,025 | 6,823 | 0 | 0 | 0 |
Total operating expenses | ||||||
41,091 | 35,678 | 27,926 | 21,094 | 0 | 0 | 0 |
Loss from operations | ||||||
-41,091 | -35,678 | -27,926 | -21,094 | 0 | 0 | 0 |
Other income: | ||||||
Interest income | ||||||
3,445 | 3,351 | 0 | 0 | 0 | - | - |
Other income, net | ||||||
0 | - | 0 | 0 | - | - | - |
Total other income | ||||||
3,469 | 3,353 | 0 | 0 | 0 | - | - |
Net loss and comprehensive loss | ||||||
-37,622 | -32,325 | -25,482 | -19,888 | 0 | 0 | 0 |
Net loss per share attributable to common stockholders, basic and diluted | ||||||
-0.34 | 6.89 | -0.26 | -1.54 | -6.89 | -4.75 | -4.36 |
Weighted-average common shares outstanding, basic and diluted | ||||||
32,897 | 33,261 | 32,707 | 5,083 | 833 | 698 | 691 |